DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Del Mastro L, Mansutti M, Bisagni G. et al.
Benefit from letrozole as extended adjuvant therapy after sequential endocrine therapy: A randomized, phase III study of Gruppo Italiano Mammella (GIM).
J Clin Oncol 2019;
DOI: 10.1200/JCO.2019.37.15_suppl.504.
We do not assume any responsibility for the contents of the web pages of other providers.